We are international
Donate
TEXT SIZE   


Lenalidomide, bortezomib, and dexamethasone has notable activity in high-risk frontline myeloma
By Paul Richardson, M.D.
XIIth International Myeloma Workshop in Washington, DC
Paul Richardson, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
02.23.09


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles